Failure of metronidazole/penicillin oral prophylaxis to prevent amputation stump infection

First Proton-Induced Cross Sections on a Stored Rare Ion Beam: Measurement of ^{118}Te(p,γ) for Explosive Nucleosynthesis.

Physical review letters·2025

Nuclear Astrophysics in the Storage Ring: Background Suppressed Simultaneous Measurement of (p,γ) and (p,n) Reactions.

Physical review letters·2025

First Direct Measurement of the 64.5 keV Resonance Strength in the ^{17}O(p,γ)^{18}F Reaction.

Physical review letters·2024

Measurement of the Isolated Nuclear Two-Photon Decay in ^{72}Ge.

Physical review letters·2024

Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO).

Trials·2023

The Multidimensional Symptom Index: A new patient-reported outcome for pain phenotyping, prognosis and treatment decisions.

European journal of pain (London, England)·2018

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026

Feasibility and Acceptability of Remote Symptom Monitoring and Wearable Activity Monitoring in Head and Neck Cancer Patients: A Mixed Methods Pilot Study.

Head & neck·2026

Early multimodal vasopressor strategy in septic shock: results of the TRICYCLE randomized controlled trial.

Critical care (London, England)·2026

Long-term outcomes of prophylactic cardioprotection in early-stage breast cancer patients on non-anthracycline anti-HER2 therapy.

Cardio-oncology (London, England)·2026

Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.

Cancer chemotherapy and pharmacology·2026

Ciprofloxacin beyond antibacterial therapy: pharmacological mechanisms, anticancer activity, and translational limitations.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Related Experiment Videos

Failure of metronidazole/penicillin oral prophylaxis to prevent amputation stump infection

Related Concept Videos

First Proton-Induced Cross Sections on a Stored Rare Ion Beam: Measurement of ^{118}Te(p,γ) for Explosive Nucleosynthesis.

Nuclear Astrophysics in the Storage Ring: Background Suppressed Simultaneous Measurement of (p,γ) and (p,n) Reactions.

First Direct Measurement of the 64.5 keV Resonance Strength in the ^{17}O(p,γ)^{18}F Reaction.

Measurement of the Isolated Nuclear Two-Photon Decay in ^{72}Ge.

Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO).

The Multidimensional Symptom Index: A new patient-reported outcome for pain phenotyping, prognosis and treatment decisions.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis.

Feasibility and Acceptability of Remote Symptom Monitoring and Wearable Activity Monitoring in Head and Neck Cancer Patients: A Mixed Methods Pilot Study.

Early multimodal vasopressor strategy in septic shock: results of the TRICYCLE randomized controlled trial.

Long-term outcomes of prophylactic cardioprotection in early-stage breast cancer patients on non-anthracycline anti-HER2 therapy.

Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.

Ciprofloxacin beyond antibacterial therapy: pharmacological mechanisms, anticancer activity, and translational limitations.

Related Experiment Videos

Failure of metronidazole/penicillin oral prophylaxis to prevent amputation stump infection

Related Concept Videos

Related Articles